ABSTRACT
Objective To evaluate the clinical efficacy of emergent endoscopic injection of tissue adhesive (N-oclyl-a-cyanoacrylate) combined with endoscopic variceal ligation (EVL) for esophageal and gastric varices bleeding. Methods Data of 21 patients with acute esophageal and gastric varices bleeding who received emergent endoscopic injection of tissue adhesive and EVL were retrospectively studied. Results The instant hemostatic rate was 95% (20/21) with no severe complications. Conclusion Emergent endoscopic injection of tissue adhesive combined with EVL is an effective and safe therapy for esophageal and gastric varices bleeding.
ABSTRACT
Objective To find out the clinical characteristics of the group of lymphoma patients with original appearance of abdominal mass through analysis of their clinical manifestation,pathology and treatment outcome.Methods Retrospective study of clinical data of 35 cases,who were admitted to PLA General Hospital from 1998 to 2003,was made as to their age,sex,pathological pattern,size of the mass at diagnosis,and accompanying symptoms,blood examination,therapy and effect with follow-up of 16~96 months.Results Seventy-four point 3 percent of the patients were male,and most of them(71.4%)with enlarged post peritoneal lymphatic nodes.Ninety-one point four percent of the patients were non-Hodgkin lymphoma and nearly half of them aged between 40 to 50.NHL patients(65.6%)of B-cell origin were more than those of T-cell origin(28.1%).One out of three HL patients died of disease relapse.Nine NHL patients died,including 6 who received conventional chemotherapy and 3 who underwent stem cell transplantation.Half of the patients(2/4)who had hepatic dysfunction and acites died.Conclusion Lymphoma patients with original appearance of abdominal mass are mostly seen in male,and most are of B cell origin.Huge mass,acites and hepatic dysfunction indicate unfavourable prognosis.LDH and ?_2-MG may be two of the prognostic factors.
ABSTRACT
To study cell cycle kinetics of acute leukemia cells and to find out its relationship with clinical treatment outcomes, flow cyto-metric measurements of cell cycle kinetics, especially percentage of S-phase cells (S%) and duration of S-phase(Ts), were made in bone marrow cells of 39 patients with acute leukemia, including 26 cases of ANLL and 13 cases of ALL. Among them 31 cases were at diagnosis and 8 were in relapes. Bromodeoxyuridine(BrdU) / DNA biparameter analysis was used, in which cells were stained with propidium iodide(PI) to estimate total cellular UNA content and a monoclonal antibody against BrdU as a probe for BrdU incorporated into DNA. The results showed that the mean S% of bone marrow cells was significantly lower than that of normal controls, while there was no significant difference between S% of patients at diagnosis and of those in relapse. However, the mean Ts was not significantly different in patients and in normal subjects, but Ts of patients in relapse was significantly shorter than that of the patients at diagnosis and that of normal controls. It is suggested that the proliferation rate of leukemic cells is lower than normal. Shorter Ts indicates faster regrowth of leukemic cells, which is closely related to relapse.
ABSTRACT
The objective of the study is to find out the synergistic effect on apoptosis resulting from the combination of chemotherapeutic drugs and some cytokines. Dexamethasone (DEX), etoposide (VP16), arsenic trioxide (As(2)O(3)) and alltrans-retinoic acid (ATRA) were added to the murine T lymphoma cell line RMA as well as to the cells preincubated with IL-2, IL-6 or GM-CSF, respectively. The effect on apoptosis was observed. All four chemotherapeutic drugs inhibited the cell proliferation. DEX, VP16 or As(2)O(3), except ATRA, singly induced apoptosis of RMA cells. The DEX concentration of inducing apoptosis was reduced when it was added together with ATRA. IL-2, IL-6 and GM-CSF did not induce apoptosis when the cytokines were added to RMA separately, however, apoptosis could be induced by combination of IL-2 and IL-6. The cytokines facilitated the apoptotic action of chemotherapeutic drugs, the drug concentration for inducing apoptosis decreased and the time period of starting apoptosis shortened. The results demonstrated that there was synergistic effect of chemotherapeutic drugs and some cytokines for induction of apoptosis. It raised an experimental basis for combination of chemotherapeutic drugs and some cytokines, especially IL-2, in the treatment of malignant lymphoma.
ABSTRACT
Objective To investigate the clonal origin of malignant cells in multifocal urothelial carcinoma. Methods p53 protein expressions were detected by immunohistochemistry in 22 pieces of tumor tissues from 10 patients with urothelial neoplasms.Mutation in p53 was inferred on the basis of immuno staining . Results The p53 protein expression of various tumors in the same patient completely matched, reflecting that the gene status of the multifocal tumor being the same. Conclusions The results strongly support the view that multifocal urothelial tumors are derived from the monoclonal cell.
ABSTRACT
To elucidate the relationship between WT1 expression and differentiation of leukemia cells and the role of WT1 gene in differentiation of leukemia cells, HL 60 and K562 cell lines were induced for 5 days by all trans retinoic acid(ATRA).Then the degree of differentiation and WT1 expression of cell lines were determined by NBT reduction assay and RT PCR respectively. The resultsshowed that only differentiation of HL 60 cells but no K562 cells could be induced by ATRA. When HL 60 cells were induced to differentiate to granulocytes by ATRA, the expression of WT1 decreased markedly during differentiation. However, WT1 transcripts were not significantly altered in K562 cells in which differentiation wasn't found. It suggested that WT1 gene expression may relate to the differentiation of leukemia cells.
ABSTRACT
Objective To determine the expression of Cyclin D 1 protein in patients with acute leukemia, and to evaluate the relationship between Cyclin D 1 expression and clinical treatment outcomes. Methods Cyclin D 1 protein was examined by immunohistochemical method in 48 acute leukemia patients, among whom 32 were ANLL and 16 were ALL, male 31, female 17, aging from 12 to 70, years with a mean of 34 4 years. It was also assayed in five normal bone marrow samples. Results There is no Cyclin D 1 protein detected in normal bone marrow cells. The positive rate of this protein in the patients is 31 3%(15/48), 25 0%(8/32)in ANLL and 43 8%(7/16)in ALL, respectively. There was no significant difference between the positive rate of the patients with ANLL and that with ALL. The positive rate of Cyclin D 1 protein was highest in the relapse group and lowest in the CR group, and the expression degree was higher in the relapse group than that in patients at the time of diagnosis. Conclusion Overexpression of Cyclin D 1 does exist in patients with leukemia, and its expression degree is correlated with progression of the disease, especially with relapse. Cyclin D 1 protein may be a prognostic factor relating to poor outcome in our study